Unicycive Therapeutics Inc (UNCY)

Finanzdaten der Unicycive Therapeutics Inc-Aktie (UNCY)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	0.675
Operating Expenses	45.79% 9.204	6.313	5.938	4.322	4.877
Interest Income/Expense	5.26% 0.02	0.019	0.018	0.032	0.012
Operating Income/Loss	45.79% -9.204	-6.313	-5.938	-4.322	-4.202
Income/Loss From Continuing Operations Before Tax	-20.96	-	-4.333	-3.838	-14.57
Income/Loss From Continuing Operations After Tax	168.83% -20.96	-7.798	-4.333	-3.838	-14.57
Net Income/Loss	168.83% -20.96	-7.798	-4.333	-3.838	-14.57
Preferred Stock Dividends And Other Adjustments	0.208	-	0.072	0.603	0.192
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	915.17% 34.91	3.4391	32.63	15.23	15.23
Diluted Average Shares	915.17% 34.91	3.4391	32.63	15.23	15.23
Basic Earnings Per Share	281.25% -0.61	-0.16	-0.13	-0.29	-0.97
Diluted Earnings Per Share	281.25% -0.61	-0.16	-0.13	-0.29	-0.97
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	0.208	-	0.072	-	-